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Background: We investigated the molecular characteristics of multidrug-resistant, extended-spectrum β-lactamase
(ESBL)-producing Enterobacteriaceae isolated in community settings and in hospitals in Antananarivo, Madagascar.
Results: Forty-nine E. coli, K. pneumoniae, K. oxytoca and E. cloacae ESBL-producing isolates were studied. In
antimicrobial susceptibility analyses, many of the isolates exhibited resistance to aminoglycosides, fluoroquinolones
and trimethoprim-sulfamethoxazole. Gene amplification analysis and sequencing revealed that 75.5% (n=37) of the
isolates harbored blaCTX-M-15 and 38.7% (n=19) harbored blaSHV-12. The non-ESBLs resistance genes detected were
blaTEM-1, blaOXA-1, aac(6
0)-Ib, aac(60)-Ib-cr, tetA, sul-1, sul-2, qnrA, qnrB and catB-3. We found dfrA and aadA gene
cassettes in the class 1 integron variable regions of the isolates, and the combination of dfrA17-aadA5 to be the
most prevalent. All blaCTX-M-15 positive isolates also contained the ISEcp1 insertion element. Conjugation and
transformation experiments indicated that 70.3% of the antibiotic resistance genes resided on plasmids. Through a PCR
based replicon typing method, plasmids carrying the blaSHV-12 or blaCTX-M-15 genes were assigned to either the IncFII
replicon type or, rarely, to the HI2 replicon type. All isolates were subtyped by the rep-PCR and ERIC-PCR methods.
Phylogenetic grouping and virulence genotyping of the E. coli isolates revealed that most of them belonged to group
A1. One isolate assigned to group B2 harbored blaCTX-M-15 and five virulence genes (traT, fyuA, iutA, iha and sfa) and
was related to the O25b-ST131 clone.
Conclusions: Our results highlight the dissemination of multidrug resistant Enterobacteriaceae isolates in Antananarivo.
These findings underline the need for a rational use of antibiotic and for appropriate methods of screening ESBL in
routine laboratories in Antananarivo.Background
Extended-spectrum β-lactamase (ESBL)-producing bacteria
represent a major worldwide threat among drug-resistant
bacteria in both hospital and community settings [1]. ESBLs
are among the Ambler classes A, confer resistance to
β-lactam antibiotics except cephamycins and carbapenems,
and are inhibited by clavulanic acid [1]. ESBLs are often
located on large plasmids that also harbor resistant* Correspondence: clara@pasteur.mg
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distribution, and reproduction in any mediumgenes to other antimicrobial classes with resulting
multidrug-resistant isolates [2].
The first ESBLs have evolved by genetic mutation from
native β-lactamases TEM and SHV [3] [4]. Recently, a
novel type of ESBLs, the CTX-M enzymes, emerged
worldwide, mostly from Enterobacteriaceae [5,6]. CTX-M
β-lactamases are not closely related to TEM or SHV
ESBLs but share high amino-acid identity with
chromosomal β-lactamases from Kluyvera spp. [7]. Now,
blaCTX-M-15 is recognized as the most widely distributed
CTX-M enzyme [8]. It is derived from CTX-M-3 by a
substitution of Asp-240-Gly which increases its catalytic
efficiency against ceftazidime [9]. blaCTX-M-15 are encodedntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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[10]. In the upstream region of CTX-M genes an insertion
sequence element, ISEcp1, is commonly present and is
likely responsible for the transposition process of the
genes [11].
E. coli is among the most prevalent causes of hospital-
acquired and community-acquired bacterial infections
and their resistances to antimicrobial agents have become
a serious concern for healthcare providers [5]. Phylogenetic
analyses have classified E. coli into four main phylogenetic
groups (A, B1, B2, and D). Commensal isolates belong
mainly to A and B1 groups whereas virulent extra-
intestinal pathogenic E. coli (ExPEC) are essentially
from the B2 and D groups [12,13]. ExPEC harbor
numerous virulence factors including α-hemolysin,
cytotoxic necrotizing factor, adhesins and iron acquisition
systems [12]. The spread of blaCTX-M-15 has been mainly
associated with the dissemination of a particular clone of
E. coli ST131 belonging to phylogenetic group B2 [14,15].
Recently, an E. coli clone O25 ST131, producing CTX-M
-15, with high virulence potential and belonging to the B2
group, has been reported and represent a major public
health problem [14,15].
Many reports have documented the emergence of ESBL-
producing Enterobacteriaceae [16-18]. In Antananarivo,
ESBLs were first detected in 2005 from UTI in 9.7% of
isolated Enterobacteriaceae [19]. In 2006, outbreaks of
CTX-M-15 and SHV-2-producing K. pneumoniae isolates
have been described in two pediatric units [20]. More
recently, 21.3% of clinical isolates from patients in surgery
and intensive care units [21] and 21.2% of intestinal
carriage isolates from children hospitalized in a pediatric
department of a large teaching hospital [22] were ESBL-
producers.
For 49 multidrug-resistant Enterobacteriaceae isolates
from Antananarivo, we characterized: i) the genes encoding
the ESBLs; ii) the drug resistance genes associated with the
ESBL genes; iii) gene cassettes present in the isolates;
and iv) the plasmid incompatibility groups of the isolates.
We also determined the phylogenetic groups and virulence
factors of the E. coli isolates.
Methods
Ethical clearance
The study protocols were approved by the National Ethics
Committee of Madagascar. Written informed consents
were obtained from all patients and at least one parent of
each child before enrollment.
Patients
Between September 2006 and December 2007, a total of
909 non-duplicate bacterial isolates were obtained from
909 patients. 830 patients were recruited from several
wards in four hospitals in Antananarivo, Madagascar(two national university teaching hospitals: Joseph
Ravoahangy Andrianavalona Hospital and Befelatanana
Hospital; a military hospital: Soavinandriana Hospital;
and a pediatric hospital: Tsaralalana Hospital) and 79
patients referred to the Pasteur Institute Medical Labora-
tory in Antananarivo.
Laboratory methods
Various clinical specimens (including blood-culture,
urine, pus, sputum and CSF) were collected and submitted
for bacterial analysis at the Pasteur Institute Medical
Laboratory in Antananarivo. Presumptive Enterobacteria
isolates were identified using standard microbiological
methods and the API 20E system (Bio-Mérieux SA, Marcy
l’Etoile, France).
Antimicrobial susceptibility testing and ESBL detection
Antimicrobial susceptibilities were determined by the
disk diffusion method on Mueller-Hinton agar (Bio-Rad,
Marne la Coquette, France) according to the guide-
lines of the Comité de l’antibiogramme de la Société
Française de Microbiologie. The following antibiotics
were tested: amoxicillin, amoxicillin-clavulanate, ticar-
cillin, cephalotin, cefamandole, cefoxitin, cefotaxime,
ceftazidime, imipenem, gentamicin, tobramycin, netilmicin,
amikacin, nalidixic acid, pefloxacin, ciprofloxacin and
trimethoprim-sulfamethoxazole.
Suspected ESBLs were confirmed by the double-disk
synergy test. E. coli ATCC 25922 and K. pneumoniae
ATCC 700603 were used as quality control strains.
Fingerprinting analysis
After DNA extraction by using the Qiagen Mini kit
(Qiagen, Courtaboeuf, France), repetitive extragenic
palindromic (Rep-PCR) and Enterobacterial repetitive
intergenic consensus sequence PCR (ERIC-PCR) were
performed with the rep-1R, rep-2 T and ERIC-2 primers,
respectively, as previously described [18]. Pattern profiles
were considered different when at least one band differed.
Molecular characterization of resistance genes
DNA was extracted by the boiling method. ESBL-encoding
genes were identified using specific primers for the blaTEM,
blaSHV, blaCTX-M and blaOXA genes, previously described
[23], and followed by DNA sequencing. Other blaCTX-M-15-
associated antibiotic resistance genes (i.e., aac(60)-Ib, qnrA,
qnrB, qnrS, tetA, sul1 and sul2) were screened by PCR
[24,25]. All positive isolates for the aac(60)-Ib gene were
further analyzed by digesting the purified PCR products
with BtsCI (New England Biolabs, Beverly, MA) to identify
aac(60)-Ib-cr, which lacks the BtsCI restriction site present
in the wild-type gene [26]. The upstream sequence of
the blaCTX-M genes was explored by PCR and
sequenced to detect ISEcp1. The integrase gene (int1)
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variable region of each class 1 integron was amplified
using specific primers for the 50 conserved segment
(50CS) and 30 conserved segment (30CS) [27], and gene
cassettes were sequenced. BlastN was used to compare
the sequences obtained to those present in the GenBank
database (http://blast.ncbi.nlm.nih.gov).
Resistance transfer assays
Conjugations were carried out in trypticase soy broth
(Bio-Rad), with E. coli J53-2 (pro, met, Rifr) as the recipient.
Mating broths were incubated at 37°C for 18 hr.
Transconjugants were selected on Drigalski agar plates
(Bio-Rad) containing rifampicin (250 μg/ml) and
cefotaxime (2.5 μg/ml).
Transfer experiments using electroporation were
performed for non-conjugative plasmids. Plasmid DNA
from donors was extracted with a QIAGEN plasmid midi
kit (QIAGEN, Courtaboeuf, France). Purified plasmids
were used to transform E. coli DH10B (Invitrogen SARL,
Cergy-Pontoise, France) by electroporation following the
manufacturer’s instructions (Bio-Rad). Transformants were
incubated at 37°C for 1.5 hr and then selected on Drigalski
agar (Bio-Rad) supplemented with 2.5 μg/ml cefotaxime.
Transconjugants and transformants were tested for
ESBL production followed by PCR amplification of the
ESBL genes and plasmid replicon typing.
Plasmid replicon type determination
Plasmid replicons from transconjugants and transformants
were determined using the PCR-based replicon typing
method described previously by Carattoli et al. Eighteen
pairs of primers targeting the FIA, FIB, FIC, HI1, HI2, I1,
L/M, N, P, W, T, A/C, K, B/O, X, Y, F and FII replicons
were used in single or multiplex PCR [28].
Phylogenetic group and virulence genotyping of E. coli
The phylogenetic groups of the E. coli isolates were
determined by PCR, [13], using a combination of three
DNA gene markers (chuA, yjaA and TSPE4-C2). All
isolates belonging to group B2 were analyzed by duplex
PCR targeting the pabB and trpA genes to determine
whether the isolate was a member of the O25b-ST131
clonal group or not [29].
The presence of 15 virulence factors found in ExPEC
was investigated by PCR with primers reported previously
[16]. These factors included fimH (type 1 fimbriae), sfa/foc
(S and F1C fimbriae), papG alleles (G adhesin classes of P
fimbriae), afa (fimbrial adhesin), hlyA (alpha-haemolysin
A), cnf (cytotoxic necrotizating factor 1), fyuA (genes of
yersiniabactin), iutA (aerobactin receptor), kpsMII (group
2 capsules), traT (genes related to complement resistance),
sat (secreted autotransporter toxin), IroN (iron related
genes) and Iha (IrgA homologue adhesin).Results
Description of the bacterial isolates
During the study period, we collected 909 isolates, of
which 830 from hospitalized patients and 79 from patients
attending the Pasteur Institute medical laboratory. Among
these, 262 were identified as E. coli (n=75), K. pneumoniae
(n=95), K. oxytoca (n=12) or E. cloacae (n=80) and 239
were ESBL-producers of which 49 were selected for
in-depth analysis. Inclusion criteria were: i) one isolate
per patient; ii) only the referent isolate, in cases of a
hospital outbreak; and iii) at least one isolate from every
ward participating in the study.
Among the 49 ESBL-producing isolates, 13 were isolated
from patients referred to the Pasteur Institute Medical
Laboratory and 36 were from hospitalized patients. Distri-
bution of isolates by hospital, ward and specimen is shown
in Table 1.
Antimicrobial susceptibility analyses showed that all
isolates were resistant to all the β-lactams used but
were susceptible to cefoxitin and imipenem. Resistance
to cefoxitin in all E. cloacae isolates was due to the
inducible production of AmpC β-lactamase from a
chromosomal gene. All ESBL-producing isolates were
also multidrug-resistant and most of them were resistant
to: aminoglycosides (87.7% to gentamicin, 93.8% to
tobramycin), trimethoprim-sulfamethoxazole (100%) and
quinolones (75.5% to nalidixic acid, 69.3% to ciprofloxacin).
Molecular epidemiology
ERIC-PCR and rep-PCR analyses revealed different
restriction patterns for each isolate and showed that they
were not clonally related (data not shown).
Molecular analysis
Nucleotide sequence analysis of the blaCTX-M and blaSHV
genes showed that only the CTX-M-15 and SHV-12 genes
were present in these isolates. Only TEM-1 and OXA-1
were identified in the TEM- and OXA-producing isolates.
The CTX-M-15 gene was detected in 37 isolates
(75.5%) and the SHV-12 gene in 19 (38%). The ISEcp1 in-
sertion sequence was identified in all 37 blaCTX-M-carrying
isolates. Of the 37 isolates positive for CTX-M-15, ten
(27%) also carried only TEM-1, nine (24.3%) also carried
only OXA-1, and 16 (43.2%) carried TEM-1 and OXA-1
genes (Table 1). Of the 19 SHV-12-positive isolates, six
(31.6%) also carried only TEM-1, four (20.1%) also carried
only OXA-1 and six (31.6%) carried TEM-1 and OXA-1
genes (Table 1). Eight isolates (16.3%) (two E. coli, five K.
pneumoniae and one E. cloacae) carried both blaCTXM-15
and blaSHV-12 and six of these were additionally TEM-1-
and OXA-1-positive.
The resistance genes most frequently present were aac
(60)-Ib (n=35, 71.4%) (33 were aac(60)-Ib-cr, 67.3%), sul1
and sul2 (n=25, 51%), tetA (n=24, 48.9%), qnrB (n=12,
Table 1 Distribution of isolates among patient category, ward and specimen types
Hospital Ward Specimen
Species No Hospital IPM HJRA HOMI Befelatanana Tsaralalana Surgery Trauma Intensive care Pediatrics Urology Dermato Pus Blood Urine Other*
E. cloacae 14 12 2 8 2 1 1 2 5 1 3 1 0 9 4 1 0
E. coli 18 14 4 12 2 0 0 3 6 3 0 1 1 12 0 4 2
K. pneumoniae 14 7 7 4 3 0 0 1 3 3 0 0 0 6 3 5 0
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carrying blaCTXM-15, blaSHV-12, blaTEM-1 and blaOXA-1, all
of these also carried aac(60)-Ib (5 were aac(60)-Ib-cr),
sul1-sul2, and five harbored tetA.
Overall β-lactam resistant isolates harbored β-lactamases
genes (CTX-M-15, SHV-12, TEM-1 and/or OXA-1) as
well as trimethoprim-sulfamethoxazole resistant isolates
sulfamide genes (sul1 and/or sul2). Ten (27.8%) of
ciprofloxacin resistant isolates and 3 (25%) of ciprofloxacin
susceptible isolates were qnr positive. Twenty five
(69.2%) of ciprofloxacin resistant isolates and 8 (61.5%)
of ciprofloxacin susceptible isolates were aac(60)-Ib-cr
positive And, 27 (71%) of amikacin susceptible isolates
and 8 (72.7%) of amikacin resistant isolates were aac
(60)-Ib positive.
Forty-eight isolates were positive for the class-1
integron gene and it was absent in only one K. oxytoca
isolate. We amplified the class 1 integrons in twenty-five
(52%) of these 48 isolates using 50CS and 30CS primers.
The sizes of the class 1 integron amplicons, which
correspond to the approximate sizes of the cassette
regions, were between 0.7 kb and 2 kb. Seven different
cassettes were identified, including the dfr gene that
encodes resistance to trimethoprim and the aadA gene
that encodes resistance to streptomycin. The two genes
most frequently associated with each other were dfrA17
and aadA5 (11/25, 22.4%) (Table 2).
Resistance transfer
Transfer of ESBL by conjugation to E. coli J53-2 was
successful for 29 (59.2%) of the 49 ESBL isolates, which
consisted of eight E. coli, eight E. cloacae and 12 K.
pneumoniae isolates and one K. oxytoca isolate. ESBL
transfer by plasmid DNA electroporation into E. coli
DH10B was successful for five (10.2%) of the 20
remaining isolates; four were E. coli isolates and one was
a K. pneumoniae isolate. The presence of blaCTX-M,
blaSHV, blaTEM and blaOXA was confirmed by PCR in the
34 transconjugants and transformants. Transfers of
non-ESBL resistance genes (tetracycline, gentamicin and
trimethoprim-sulfamethoxazole) were also detected by
antimicrobial susceptibility testing.
Plasmid replicon type determination
PCR-based replicon typing in the 34 transconjugants
and transformants demonstrated the presence of the
IncFII, HI2 and FIA replicons in these isolates (Table 3).
IncFII was the most prevalent replicon type and was
detected in 20 (58.8%) (10 E. coli and 10 K. pneumoniae)
of the 34 isolates. HI2 was found in 13 (38.2%) isolates
(eight E. cloacae, three K. pneumoniae, one E. coli and
one K. oxytoca) and FIA was found in one E. coli isolate.
The plasmids carrying blaCTX-M-15 were assigned to the
FII (n=12) and HI2 (n=8) replicon types. Plasmidscarrying blaSHV-12 (n=5) or carrying both blaCTX-M-15
and blaSHV-12 (n=2) were assigned to FII.
E. coli phylogenetic groups and virulence factors
Phylogenetic analysis of the 18 E. coli isolates revealed
four main phylogenetic groups (A1, B1, B2 and D). Most
of these isolates belonged to group A1 (77.7%, n=14), 11
of which were isolated from pus. All 18 isolates harbored
genes related to complement resistance (traT) but none
harbored any of the papG alleles or the fimH, afa, hlyA,
cnf1, kpsMII or sat genes. Ten isolates from groups A1,
B1 and D harbored genes encoding siderophores (fyuA,
iutA and IroN) (Table 4).
The single E. coli isolate in the B2 group was an
O25b-ST131 clone and was isolated from the urine of a
hospitalized patient. This E. coli isolate harbored
blaCTX-M-15, tetA, aac(6
0)-Ib-cr and sul1-sul2, and was
assigned to the FII replicon type. Genes encoding
siderophore (fyuA and iutA) and genes involved in the
formation of adhesins (iha) or fimbriae (sfa) were
detected in this isolate, but it produced neither cytotoxin
nor hemolysin.
Discussion
We extensively characterized 49 ESBL-producing
Enterobacteriaceae collected over a period of 15 months
in four hospitals and at the Pasteur Institute Medical
Laboratory. Previous studies in Antananarivo have shown
resistant bacteria clonal diffusion in hospital settings
[20,30], but among the 49 non-representative ESBL-
producing Enterobacteriaceae studied, no clonal isolates
have been found.
The blaCTX-M-15 ESBL gene is considered to be the
most prevalent ESBL worldwide [17,18,23,31,32]. We
also found blaCTX-M-15 to be the most prevalent ESBL in
Madagascar, as it was detected in 75.5% of the isolates
we studied. A study involving nine Asian countries
reported that blaCTX-M-15 was highly prevalent among
ESBL-producing K. pneumoniae isolates (60%, 55/92)
[17]. In Tunisia, Dahmen et al. reported that 91% of
the ESBL-producing isolates carried blaCTX-M-15 genes
[23]. Our findings are intermediate between those
found in Asia and in Tunisia and confirm the
predominance of blaCTX-M-15 among ESBL-producing
isolates. In Antananarivo, a previous study conducted
in the neonatal units of two hospitals in 2006
documented that a clonal outbreak of K. pneumoniae
harbored blaCTX-M-15 and blaSHV-2 genes [20]. In 2009, a
community-based study of the intestinal carriage of 49
ESBL-producing Enterobacteriaceae demonstrated that
the most prevalent ESBL gene was blaCTX-M-15 (93.9%),
followed by blaCTX-M-3, blaSHV-12 and blaSHV-2a [33]. The
presences of blaCTX-M-15, blaCTX-M-3, blaSHV-2 and blaSHV-12
is not surprising as molecular analysis indicated that
Table 2 Characteristics of ESBL-producing Enterobacteriaceae isolates and their associated drug resistance genes and gene cassettes
ESBLs Other
β-lactamases
Associated drug resistance genes Gene cassettes
Species No CTX-M-15 SHV-12 Both TEM-1 OXA-1 TetA aac6'-1b aac6'-1b-cr qnrA qnrB catB3 sul1 sul2 sul1- sul2 aadA1 aadA2 aadA4 aadA5 dfrA5 drA22 dfrA17-
aadA5
E. coli 18 14 2 2 12 13 8 14 13 0 3 0 2 3 8 2 1 1 1 2 0 6
K. pneumoniae 14 6 3 5 7 13 9 13 13 0 5 4 2 5 7 0 2 0 0 1 1 3
K. oxytoca 3 1 2 0 1 0 0 0 0 0 0 0 0 0 2 0 0 0 1 0 0 0
E. cloacae 14 8 4 1 12 2 7 8 7 1 4 0 0 6 8 0 1 1 0 0 0 2


















Table 3 β-lactamase genes transferred to transconjugants and electroporants and their replicon type
β-lactamase genes Replicon type Transconjugants Electroporants
E. coli K. pneumoniae K. oxytoca E. cloacae Totals E. coli K. pneumoniae Totals
CTX-M-15 FII 2 1 0 0 3 2 0 2
HI2 0 1 0 1 2 0 0
FIA/FIB 1 0 0 0 1 0 0
SHV-12 FII 0 3 0 0 3 1 0 1
OXA-1 FII 0 1 0 0 1 0 0
CTX-M-15+TEM-1 FII 0 0 0 0 1 0 1
HI2 0 0 1 6 7 0 0
CTX-M-15+OXA-1 FII 3 3 0 0 6 0 0
HI2 1 1 0 0 2 0 0
SHV-12+TEM-1 FII 1 0 0 0 1 0 0
TEM-1+OXA-1 HI2 0 0 0 1 1 0 0
CTX-M-15+SHV-12+TEM-1 FII 0 0 0 0 0 1 1
CTX-M-15+TEM-1+OXA-1 HI2 0 1 0 0 1 0 0
CTX-M-15+SHV-12+OXA-1 FII 0 1 0 0 1 0 0
Totals 8 12 1 8 29 4 1 5
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from blaSHV-2 [34].
CTX-M genes may disseminate through clonal expansion
or horizontal gene transfer [35,36]. In our study, ISEcp1
was found upstream from blaCTX-M-15 at variable distances,
as was previously described [18]. ISEcp1 was found to
be in the vicinity of many blaCTX-M genes (including
blaCTX-M-15) and was reported to contain sequences
resembling a typical promoter region [11]. Then, plasmids
carrying blaCTX-M-15 were assigned to the IncFII, IncFIA
or IncHI2 incompatibility group replicons. Association of
the blaCTX-M-15 gene with IncF plasmids carrying the FII
replicon in association with the FIA or FIB replicon has
been reported previously for isolates in Canada, France,
Spain, Tunisia, and the United Kingdom [35,36]. The first
evidence of the association of the FII plasmid with the
blaCTX-M-15 gene was demonstrated by sequencing the
entire pC15-1a plasmid from epidemic E. coli isolated in
Canada [2]. The IncHI2 plasmid, frequently associated
with blaCTX-M-2 or blaCTX-M-9, was first identified inTable 4 Phylogenetic and virulence factors in the E. coli isolat
Phylogenetic No Specimen
group Pus* Urine Sputum C
A1 14 11 1 1
B1 2 1 1 0
B2 1 0 1 0
D1 1 0 1 0
Totals 18 12 4 1
*Deep pus, surgical wounds.Serratia marcescens [10], but rarely reported in association
with blaCTX-M-15.
Like blaCTX-M-15, blaSHV-12 is also widely distributed.
In our study, 38% of the isolates harbored blaSHV-12.
First described in Switzerland [37] and subsequently found
in various continents, including Africa [38], blaSHV-12 is
most often found in Asia [34]. Plasmids carrying blaSHV-12
were assigned to the IncFII replicon, as previously
reported in France [39]. Evolutionary analysis of GenBank
sequences indicated that blaSHV-12 evolved from the
branch of blaSHV-2a [34]. Although it is possible that this
transformation occurred in Antananarivo, as blaSHV-2a
was reported in neonatal units in 2009 [20]. It can also be
assumed that the local emergence of blaSHV-12 could be
explained by introduction of international clones.
Our antimicrobial susceptibility analysis of the ESBL-
producing isolates found highly prevalent resistances to
gentamicin (87.7%); tobramycin (93.8%); ciprofloxacin
(69.3%) and to trimethoprim-sulfamethoxazole (100%) and
confirm the presence of multidrug-resistant isolates ines
Virulence factor
SF fyuA iutA sfa IroN Iha traT
1 3 6 0 2 0 14
0 1 1 0 0 0 2
0 1 1 1 0 1 1
0 1 1 0 0 0 1
1 6 9 1 2 1 18
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among ESBL-producing isolates is of great clinical
relevance due to the severely limited therapeutic options
and the high risk of treatment failure in patients infected
with these strains.
Genes encoding ESBLs are often associated with
determinants of resistance to other antimicrobial agents,
including aminoglycosides (aac(6)-Ib), fluoroquinolones
(qnr), tetracycline (tetA), and trimethoprim-sulfamethoxa-
zole (sul) and are frequently located on plasmids
belonging to the IncF group [10]. In this study, we found
the first example in Madagascar of the plasmid-mediated
quinolone resistance (PMQR) genes: qnrB (24.5%) and
qnrA (2%), and a variant gene aac(60)-Ib-cr (67.3%) that
encodes an aminoglycoside-modifying enzyme. Qnr gene
prevalence was higher in the K. pneumoniae (41.7%)
isolates than in the E. coli (25%) isolates, which has
been noted by other authors [24,40]. The aac(60)-Ib-cr
gene accounted for 94.3% (33/35) of the aac(60)-Ib genes
detected. This high proportion of aac(60)-Ib-cr/aac(60)-Ib
was also observed in a previous study [40]. The PMQR
genes qnr and aac(60)-Ib-cr are now recognized to be
geographically widespread [24,25]. These genes have
been previously reported to be associated with ESBLs.
The horizontal transfer of plasmids harboring genes
encoding for ESBLs and PMQR genes could have
promoted this co-resistance.
The cassette region could not be amplified by PCR in
23 class 1 integron-containing isolates, which may have
been due to the lack of the 30CS. The analysis of 25
cassette regions revealed a predominance of aadA and
dfrA genes, which confer resistance to aminoglycosides
and trimethoprim, respectively. This result correlates
with previous studies of African Enterobacteriaceae isolates
[27,41]. The combination of dfrA17-aadA5 (22%) was the
one most frequently detected in our study. Similar findings
were reported for isolates from Taiwan and Tunisia, as
dfrA17-aadA5 was found in 81 of 224 (36%) and in 3 of 4
(75%) E. coli class 1 integrons, respectively [42,43].
Analysis of the phylogenetic groups and virulence factors
of E. coli isolates revealed that most of these isolates
belong to group A1. The phylogenetic group A1 consists
of commensal enteric E. coli and may therefore be the
natural reservoir of pathogenic isolates. Pathogenic E. coli
isolates may have derived from commensal isolates by
acquiring chromosomal or extra chromosomal virulence
operons [44]. Although virulence determinants are
considered to be mobile, strain phylogeny and virulence
may be linked [45]. The B2 phylogenetic group, which
diverges from the commensal isolates, evolved toward
extra intestinal virulence by acquiring numerous patho-
genic determinants [12].
We also encountered an E. coli isolate belonging to
group B2, harboring blaCTX-M-15 and other resistancegenes, and corresponding to the worldwide pandemic
clone O25b-ST131. It has been reported that most
O25-ST131 isolates are multidrug-resistant, produce
CTX-M-15 ESBL enzymes [14] and harbor virulence
genes required for pathogenic invasion of hosts. In one
study, the genes for adhesins (iha, fimH), siderophores
(fyuA, iutA) and the toxin (sat) were found in 95% - 100%
of the O25b-ST131 E. coli isolates [14], but typical
fimbriae and pilus genes, such as those encoded by the
papA allele, were not. In Africa, few data exist on the
presence of ST131. In a South African study, 43% of 23
isolates were ST131 [46]; as were 50% of the CTX-M-15-
producing E. coli isolates collected in the Central African
Republic [13]. The presence of this clone in Antananarivo
hospitals is of concern and further studies should be
conducted to assess its prevalence.
Conclusion
Our results highlight the dissemination of multidrug
resistant Enterobacteriaceae isolates in Antananarivo, in
different hospital settings and probably in the community.
These findings underline the need for a rational use of
antibiotic and for appropriate methods of screening ESBL
in routine laboratories in Antananarivo.
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